⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASND News
Ascendis Pharma A/S American Depositary Shares
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
globenewswire.com
ASND
Laudio Releases Second Edition of Award-Winning Book for Frontline Healthcare Leaders, “Leader Inspired Work”
globenewswire.com
ASND
Ascendion Named a Market Leader for Agentic Services by HFS Research
prnewswire.com
ASND
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
globenewswire.com
ASND
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
globenewswire.com
ASND
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
globenewswire.com
ASND
New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52
globenewswire.com
ASND
New Two-Year Data from Pivotal ApproaCH Trial Showing Durable Benefits of TransCon® CNP (Navepegritide) in Children with Achondroplasia Shared at ACMG 2026
globenewswire.com
ASND
Liberty All-Star® Growth Fund, Inc. February 2026 Monthly Update
businesswire.com
NVDA
AAPL
GOOGL
MSFT
META
AMZN
CW
OLLI
AVGO
LGN
MPWR
ARTV
ASND
LLY
NVT
CAT
FTAI
LOW
PLTR
TKO
PINS
UNH
Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy
prnewswire.com
GILD
ASND
ABBV